Advertisement

Endocrine Pathology

, Volume 29, Issue 1, pp 86–88 | Cite as

Antidepressant-Related Black Thyroid

  • Jean-Luc Barras
  • Rossella Sarro
  • Massimo Bongiovanni
  • Stefano La Rosa
Article

Case History

In 2010, a 61-year-old Caucasian woman presented with a palpable thyroid goiter associated with hyperthyroidism and started carbimazole therapy. Her medical history also included long standing anxious-depressive troubles treated with lithium and tricyclic antidepressants for several years and, successively, with paroxetine. In addition, she suffered of type 2 diabetes mellitus, arterial hypertension, mixed dyslipidemia, and osteoporosis. She never used minocycline or related tetracycline antibiotics. She underwent thyroid scintigraphy that showed a hot left nodule and a cold right nodule. Fine needle aspiration (FNA) of both nodules was performed. Unfortunately, FNA of the right nodule was non-diagnostic, while the left one was benign. Then, she disappeared from clinical surveillance and 6 years later, she presented to her general practitioner who, on the basis of her psychiatric troubles which made her unable to follow the correct thyroid therapy, suggested a complete...

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no competing interests.

References

  1. 1.
    Nosé V (2016) Drug- and radiation-induced changes and pigment accumulation. In: Mete O, Asa SL (eds) Endocrine Pathology. Cambridge, Cambridge University Press, pp. 422–424Google Scholar
  2. 2.
    Benitz KF, Roberts GK, Yusa A (1967) Morphologic effects of minocycline in laboratory animals. Toxicol Appl Pharmacol 11:150–170CrossRefPubMedGoogle Scholar
  3. 3.
    Attwood HD, Dennett X (1976) A black thyroid and minocycline treatment. Br Med J 2:1109–1110CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Pastolero GC, Asa SL (1994) Drug-related pigmentation of the thyroid associated with papillary carcinoma. Arch Pathol Lab Med 118:79–83PubMedGoogle Scholar
  5. 5.
    Chernock RD, Jackson RS (2017) Novel cause of 'black thyroid': intraoperative use of indocyanine green. Endocr Pathol 28:244–246CrossRefPubMedGoogle Scholar
  6. 6.
    Landas SK, Schelper RL, Tio FO, Turner JW, Moore KC, Bennett-Gray J (1986) Black thyroid syndrome: exaggeration of a normal process? Am J Clin Pathol 85:411–418CrossRefPubMedGoogle Scholar
  7. 7.
    Alexander CB, Herrera GA, Jaffe K, Yu H (1985) Black thyroid: clinical manifestations, ultrastructural findings, and possible mechanisms. Hum Pathol 16:72–78CrossRefPubMedGoogle Scholar
  8. 8.
    Ibrahim Y, Crawford BE, Murci M, Masoodi H, Khan AN, Hu T, et al. (2015) Thyroid cancer in black thyroid glands: the effect of age and race. ORL J Otorhinolaryngol Relat Spec 77:33–38CrossRefPubMedGoogle Scholar
  9. 9.
    Bruins NA, Oswald JE, Morreau H, Kievit J, Pavel S, Smelt AH (2007) Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline. Neth J Med 65:185–187PubMedGoogle Scholar
  10. 10.
    Hecht DA, Wenig BM, Sessions RB (1999) Black thyroid: A collaborative series. Otolaryngol Head Neck Surg 121:293–296CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Jean-Luc Barras
    • 1
  • Rossella Sarro
    • 1
  • Massimo Bongiovanni
    • 1
  • Stefano La Rosa
    • 1
  1. 1.Service of Clinical PathologyLausanne University Hospital, Institute of PathologyLausanneSwitzerland

Personalised recommendations